Key result
The Na+/H+ exchange inhibitor HOE642 improved postischemic functional recovery in both mature (84.4% vs 63.1%) and aged (85.9% vs 59.5%) isolated rabbit hearts compared to untreated controls (p<0.05).
Why the study?
Does HOE642 improve postischemic functional recovery and reduce infarct size in isolated aged and mature rabbit hearts subjected to ischemia/reperfusion?
Does HOE642 improve postischemic functional recovery and reduce infarct size in isolated aged and mature rabbit hearts subjected to ischemia/reperfusion?
Absolute Event Rate: 85.9% vs 59.5%
p-value: p=< 0.05
The Na+/H+ exchange inhibitor HOE642 provides myoprotection against ischemia-reperfusion injury in both senescent and mature rabbit hearts.
Does not support clinical use; leaves open translation of NHE inhibition to aged human myocardium.
BACKGROUND: Inhibition of Na(+)/H(+) exchange has been shown to provide functional protection during ischemia and reperfusion in mature heart. This study was undertaken to elucidate the effect of Na(+)/H(+) exchange inhibitor HOE642 in the aged rabbit heart. METHODS: Isolated rabbit hearts were subjected to 1 h of left descending coronary artery (LAD) ischemia and 1 h of reperfusion. To determine the effects of HOE642 on ischemia/reperfusion injury, seven aged or mature hearts received the Na(+)/H(+) exchange inhibitor HOE642 (1 microM) for 15 min before the ischemia and for 30 min after reperfusion. Seven aged (more than 135 weeks) or mature (15-20 weeks) rabbit hearts served as a control (untreated) with no interventions. Left ventricular pressures, monophasic action potentials and coronary flows were measured throughout the experiment and infarct size was detected at the end of experiment. RESULTS: (1) In the mature hearts, HOE642 improved postischemic functional recovery (63.1 +/- 5.0% vs. 84.4 +/- 5.4%, mature untreated vs. mature HOE, p < 0.05) and reduced infarct size as compared to untreated hearts (42.0 +/- 2.5% vs. 24.8 +/- 2.3%, mature untreated vs. mature HOE, p < 0.05). (2) Although infarct size in aged untreated hearts was significantly decreased as compared to mature untreated hearts (42.0 +/- 2.5% vs. 19.3 +/- 1.6%, mature untreated vs. aged untreated, p < 0.05), there are no significant differences regarding postischemic functional recovery between mature and aged untreated hearts (63.1 +/- 5.0% vs. 59.5 +/- 5.9%, mature untreated vs. aged untreated, p = n.s.). (3) In the aged hearts, HOE642 improved postischemic functional recovery as compared to untreated hearts (59.5 +/- 5.9% vs. 85.9 +/- 8.1%, aged untreated vs. aged HOE, p < 0.05). CONCLUSION: Na(+)/H(+) exchange inhibitor HOE642 is effective against ischemia-reperfusion injury in senescent as well as mature hearts.
No takes yet. Share an insight, caveat, or question.
Nakai et al. (2002) studied Ischemia/reperfusion injury (n=28). HOE642 vs. Untreated control was evaluated on Postischemic functional recovery in aged hearts (p=< 0.05). The Na+/H+ exchange inhibitor HOE642 improved postischemic functional recovery in both mature (84.4% vs 63.1%) and aged (85.9% vs 59.5%) isolated rabbit hearts compared to untreated controls (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: